Anti-neoplastic compositions comprising extracts of black cohosh
AssigneeResearch Foundation of the City University of New York
InventorLinda Saxe Einbond
Life of this patent
Estimating the term…
Loading patent…
AssigneeResearch Foundation of the City University of New York
InventorLinda Saxe Einbond
Estimating the term…
A method for treating, preventing or ameliorating breast cancer is provided by administering a synergistic amount of digitoxin and either actein or an extract of black cohosh comprising triterpene glycosides, and optionally another chemopreventive agent which may be paclitaxel. Methods for treating or preventing a neoplasia using a synergistic combination, and compositions of a synergistic combination of a cardiac glycoside and either actein or an extract of black cohosh comprising triterpene glycosides, and optionally another chemopreventive agent which may be a taxane are also provided. The compositions may also be used in a method for modulating Na+K+ATPase activity. In addition, a method for inhibiting the progression or development of breast cancer in vivo by administering either actein or an extract of black cohosh comprising triterpene glycosides and optionally at least one other chemoprotective agent is provided.
A composition for use in treating or preventing neoplasia, comprising an effective anti-neoplastic amount of a methylene chloride extract of black cohosh.
A composition of anti-neoplastic agents, comprising an effective anti-neoplastic amount of a methylene chloride extract of black cohosh and an effective anti-neoplastic amount of at least one additional chemopreventive or chemotherapeutic agent.
A method for treating or preventing neoplasia in a human, comprising administering to the human an amount of a methylene chloride extract of black cohosh effective to treat or prevent the neoplasia.
A method for treating or preventing neoplasia in a human, comprising administering to the human an amount of a methylene chloride extract of black cohosh effective to treat or prevent the neoplasia, in combination with an amount of at least one additional chemopreventive or chemotherapeutic agent effective to treat or prevent the neoplasia.
Dependencies are inferred from the claim text.